Испанская больница внедрила технологию удаленной настройки стимуляторов мозга для лечения Паркинсона

Remote programming of deep brain stimulation (DBS) may expand access to specialist care by allowing clinicians to adjust therapy from a distance and reduce follow-up visits. The Fundación Jiménez Díaz University Hospital in Madrid, Spain, announced the introduction of a new generation of neurostimulators that enable remote adjustment of DBS in a press release. Technology represents another step in the evolution of DBS, which has transformed the treatment of conditions such as Parkinson’s disease, essential tremors, and dystonia. Newly implanted neurostimulators allow neurologists to monitor clinical parameters and adjust stimulation settings through secure digital platforms, eliminating the need for patients to return to the hospital for routine programming. How DBS Works A neurostimulator is an implantable medical device that delivers low-intensity electrical impulses to specific brain circuits to reduce symptoms such as tremors, rigidity, and involuntary movements. From a biophysical perspective, DBS does not replace normal brain activity. Instead, it generates an electrical field that changes the excitability of the targeted neurons, altering how they generate and transmit electrical signals. The therapy neither destroys the brain tissue nor cures the underlying disease. Rather, it modulates dysfunctional neural networks to improve symptom control and patient quality of life. Components of a Neurostimulator The DBS system consists of four main components: - Electrodes: Implanted in specific regions of the brain associated with the patient’s condition to deliver electrical stimulation to targeted neural tissues. - Implantable pulse generator: The system’s control unit is typically implanted beneath the skin below the clavicle or in the upper chest. It regulates the intensity, frequency, and duration of electrical stimulation and stores the programmed treatment settings. - Extension leads: Connect the electrodes to the implantable pulse generator. - Programming and telemetry system: This allows clinicians to adjust various electrical stimulation parameters noninvasively, without the need for surgery. Beyond Surgery DBS should not be viewed as a one-time surgical procedure because treatment continues well beyond device implantation. Its success depends on careful postoperative programming, with stimulation parameters adjusted over time to achieve the best possible therapeutic response. Programming is not a one-time process. As the underlying disease progresses and patient responses to therapy change, the neurostimulator requires periodic reprogramming to maintain optimal symptom control. Thus, DBS is a dynamic therapy that evolves with the patient’s clinical needs. Traditionally, these adjustments have required patients to return to the hospital for repeated programming sessions, resulting in frequent travel and an additional burden on both patients and healthcare services. Remote Follow-Up The integration of telemedicine with remote programming represents an important advancement in the long-term management of DBS. It enables more continuous, efficient, and accessible follow-up while supporting a more personalized approach to patient care. For specialists, technology offers a new way to deliver long-term care. As highlighted in the hospital’s press release, a patient living in Peru will continue receiving follow-up from the same multidisciplinary team in Madrid that implanted the device. The case illustrates how remote programming can extend specialized neurologic care across geographical boundaries. The authors reported having no relevant conflicts of interest. This story was translated from Univadis Spain, part of the Medscape Professional Network.